Literature DB >> 11226719

Sexual diergism in rat hypothalamic-pituitary-adrenal axis responses to cholinergic stimulation and antagonism.

M E Rhodes1, S M O'Toole, S L Wright, R K Czambel, R T Rubin.   

Abstract

The hypothalamic-pituitary-adrenal (HPA) axis has differential physiological activity in male and female animals (sexual diergism). Central cholinergic systems stimulate this endocrine axis. In the present study we investigated muscarinic and nicotinic cholinergic influences on HPA axis activity in male and female rats by pretreatment with selective cholinergic receptor antagonists followed by stimulation with physostigmine (PHYSO), an acetylcholinesterase inhibitor. Hormonal measures were plasma arginine vasopressin (AVP), adrenocorticotropic hormone (ACTH), and corticosterone (CORT). Male rats had significantly greater AVP and ACTH responses to PHYSO alone than did females. Scopolamine (SCOP) enhanced the AVP response to PHYSO to a greater extent in males than in females. In contrast, mecamylamine (MEC) enhanced the AVP response in females but decreased it in males. SCOP potentiated, and MEC inhibited, the stimulatory effect of PHYSO on ACTH in both sexes, but SCOP potentiation was greater in males, and MEC inhibition was greater in females. Absolute CORT increases following PHYSO were greater in females, but percent increases over baseline were greater in males. Similar to their effects on ACTH responses, MEC attenuated, and SCOP enhanced, CORT responses to PHYSO. These results suggest that cholinergic receptor subtypes may influence HPA axis activity differentially in male and female rats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226719     DOI: 10.1016/s0361-9230(00)00449-4

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  11 in total

1.  Sexually diergic, dose-dependent hypothalamic-pituitary-adrenal axis responses to nicotine in a dynamic in vitro perfusion system.

Authors:  Jessica M McKlveen; Jared M Wilson; Robert T Rubin; Michael E Rhodes
Journal:  J Pharmacol Toxicol Methods       Date:  2010-02-01       Impact factor: 1.950

Review 2.  Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature.

Authors:  Noah S Philip; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price
Journal:  Psychopharmacology (Berl)       Date:  2010-07-08       Impact factor: 4.530

3.  Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression.

Authors:  Michelle M Mielke; Jeannie-Marie Leoutsakos; Chris D Corcoran; Robert C Green; Maria C Norton; Kathleen A Welsh-Bohmer; JoAnn T Tschanz; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2012-02-01       Impact factor: 21.566

4.  Sexually diergic hypothalamic-pituitary-adrenal axis responses to selective and non-selective muscarinic antagonists prior to cholinergic stimulation by physostigmine in rats.

Authors:  Marissa A Smail; Jessica L Soles; Tracy E Karwoski; Robert T Rubin; Michael E Rhodes
Journal:  Brain Res Bull       Date:  2017-11-07       Impact factor: 4.077

5.  Influence of environmental enrichment on hypothalamic-pituitary-adrenal (HPA) responses to single-dose nicotine, continuous nicotine by osmotic mini-pumps, and nicotine withdrawal by mecamylamine in male and female rats.

Authors:  Amanda J Skwara; Tracy E Karwoski; R Kenneth Czambel; Robert T Rubin; Michael E Rhodes
Journal:  Behav Brain Res       Date:  2012-06-13       Impact factor: 3.332

Review 6.  Sex as a biological variable in the pathology and pharmacology of neurodegenerative and neurovascular diseases.

Authors:  Pedram Honarpisheh; Louise D McCullough
Journal:  Br J Pharmacol       Date:  2019-05-21       Impact factor: 8.739

7.  Sexually diergic hypothalamic-pituitary-adrenal (HPA) responses to single-dose nicotine, continuous nicotine infusion, and nicotine withdrawal by mecamylamine in rats.

Authors:  Natalie E Gentile; Julie D Andrekanic; Tracy E Karwoski; R Kenneth Czambel; Robert T Rubin; Michael E Rhodes
Journal:  Brain Res Bull       Date:  2011-03-17       Impact factor: 4.077

8.  A subchronic application period of glucocorticoids leads to rat cognitive dysfunction whereas physostigmine induces a mild neuroprotection.

Authors:  Katrin Wüppen; Dirk Oesterle; Sabina Lewicka; Jürgen Kopitz; Konstanze Plaschke
Journal:  J Neural Transm (Vienna)       Date:  2010-07-27       Impact factor: 3.575

9.  Effects of short-term varenicline administration on cortisol in healthy, non-smoking adults: a randomized, double-blind, study.

Authors:  Roel J T Mocking; Stephany A Wever; C Patrick Pflanz; Abbie Pringle; Elizabeth Parsons; Sarah F McTavish; Phil J Cowen; Catherine J Harmer; Aart H Schene
Journal:  Psychopharmacology (Berl)       Date:  2013-07-28       Impact factor: 4.530

10.  Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause.

Authors:  Virginia M Miller; Vesna D Garovic; Kejal Kantarci; Jill N Barnes; Muthuvel Jayachandran; Michelle M Mielke; Michael J Joyner; Lynne T Shuster; Walter A Rocca
Journal:  Biol Sex Differ       Date:  2013-03-28       Impact factor: 5.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.